AccuRna Competitors and Similar CompaniesClear all
AccuRna's competitors and similar companies include Walvax Biotechnology.
 AccuRna AccuRna (株式会社アキュルナ) is a company developing a drug delivery system (DDS) for nucleic acid therapeutics, both of short chain including ASO, siRNA, miRNA and long chain, mRNA as a therapeutic drug.
|  Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | |
Founding Date | Founding Date 2015 | Founding Date 2001 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Bunkyo City, JP HQ Kawasaki, JP | Locations Kunming, CN HQ |
Employees | Employees 6 | Employees 2,388 |
Funding | ||
Total funding raised | Total funding raised $ 6.5m | Total funding raised $ 72.8m |
For sources of this data, please see the company profile
View Company Profiles
Walvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View company